Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthritis, Rheumatoid | 8 | 2010 | 3695 | 0.410 |
Why?
|
| Peptides, Cyclic | 1 | 2009 | 401 | 0.280 |
Why?
|
| Antirheumatic Agents | 2 | 2010 | 1335 | 0.230 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2002 | 215 | 0.190 |
Why?
|
| Antibodies | 1 | 2009 | 2459 | 0.190 |
Why?
|
| Thrombin | 1 | 2002 | 598 | 0.180 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4414 | 0.160 |
Why?
|
| Enzyme Inhibitors | 3 | 2003 | 3800 | 0.130 |
Why?
|
| Antibodies, Monoclonal | 1 | 2010 | 9274 | 0.110 |
Why?
|
| Polymorphism, Single Nucleotide | 7 | 2010 | 15494 | 0.100 |
Why?
|
| Genome-Wide Association Study | 2 | 2010 | 12220 | 0.090 |
Why?
|
| Vitreoretinopathy, Proliferative | 1 | 2010 | 68 | 0.090 |
Why?
|
| Nucleotide Deaminases | 1 | 2009 | 11 | 0.090 |
Why?
|
| Hydroxymethyl and Formyl Transferases | 1 | 2009 | 17 | 0.090 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 217 | 0.090 |
Why?
|
| Metacarpal Bones | 1 | 2009 | 73 | 0.080 |
Why?
|
| Acetylcysteine | 1 | 2010 | 272 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 5 | 2010 | 17400 | 0.080 |
Why?
|
| HLA-DR Antigens | 1 | 2009 | 644 | 0.070 |
Why?
|
| Prolactin | 1 | 2009 | 669 | 0.070 |
Why?
|
| Chromosomes, Human | 1 | 2008 | 457 | 0.070 |
Why?
|
| Retinal Detachment | 1 | 2010 | 411 | 0.070 |
Why?
|
| Major Histocompatibility Complex | 1 | 2009 | 935 | 0.070 |
Why?
|
| Multienzyme Complexes | 1 | 2009 | 686 | 0.060 |
Why?
|
| Indoles | 2 | 2003 | 1834 | 0.060 |
Why?
|
| International Cooperation | 1 | 2010 | 1421 | 0.060 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 2003 | 113 | 0.060 |
Why?
|
| Disability Evaluation | 1 | 2010 | 1827 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 2003 | 3133 | 0.050 |
Why?
|
| Lactams | 1 | 2003 | 155 | 0.050 |
Why?
|
| Methotrexate | 1 | 2009 | 1720 | 0.050 |
Why?
|
| Antioxidants | 1 | 2010 | 1659 | 0.050 |
Why?
|
| Biological Availability | 1 | 2002 | 396 | 0.050 |
Why?
|
| Haplotypes | 1 | 2008 | 2781 | 0.050 |
Why?
|
| Indicators and Reagents | 1 | 2002 | 462 | 0.050 |
Why?
|
| Sulfones | 1 | 2003 | 437 | 0.050 |
Why?
|
| Heterocyclic Compounds | 1 | 2002 | 249 | 0.050 |
Why?
|
| Lactones | 1 | 2003 | 329 | 0.050 |
Why?
|
| Genetic Loci | 1 | 2010 | 2572 | 0.050 |
Why?
|
| Genotype | 3 | 2009 | 12946 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2003 | 578 | 0.040 |
Why?
|
| Antithrombins | 1 | 2002 | 304 | 0.040 |
Why?
|
| Repressor Proteins | 1 | 2009 | 3020 | 0.040 |
Why?
|
| Arginine | 1 | 2002 | 944 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2002 | 1653 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 3769 | 0.040 |
Why?
|
| Crystallography, X-Ray | 1 | 2002 | 2014 | 0.040 |
Why?
|
| Health Status | 1 | 2010 | 4030 | 0.040 |
Why?
|
| Bone Density | 1 | 2009 | 3469 | 0.040 |
Why?
|
| Multiple Sclerosis | 1 | 2009 | 3076 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 6313 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2009 | 6540 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 15530 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18006 | 0.020 |
Why?
|
| Risk Factors | 4 | 2010 | 72145 | 0.020 |
Why?
|
| Middle Aged | 5 | 2010 | 213127 | 0.020 |
Why?
|
| Rats | 2 | 2003 | 24265 | 0.020 |
Why?
|
| Algorithms | 1 | 2009 | 13853 | 0.020 |
Why?
|
| Vitreous Body | 1 | 2010 | 389 | 0.020 |
Why?
|
| Alleles | 2 | 2009 | 6931 | 0.020 |
Why?
|
| Dogs | 2 | 2003 | 3910 | 0.020 |
Why?
|
| Female | 7 | 2010 | 379592 | 0.020 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2010 | 302 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2010 | 62966 | 0.020 |
Why?
|
| Humans | 11 | 2010 | 742088 | 0.020 |
Why?
|
| Male | 4 | 2010 | 349538 | 0.020 |
Why?
|
| Aged | 4 | 2009 | 162944 | 0.020 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 1364 | 0.020 |
Why?
|
| Rabbits | 1 | 2010 | 4886 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2009 | 1726 | 0.010 |
Why?
|
| Environment | 1 | 2009 | 1115 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2003 | 191 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2422 | 0.010 |
Why?
|
| Hip Joint | 1 | 2009 | 1002 | 0.010 |
Why?
|
| Reactive Oxygen Species | 1 | 2010 | 2077 | 0.010 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2003 | 459 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3510 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2003 | 677 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2010 | 2036 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2009 | 2015 | 0.010 |
Why?
|
| Case-Control Studies | 2 | 2009 | 21719 | 0.010 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2003 | 731 | 0.010 |
Why?
|
| Postmenopause | 1 | 2009 | 2461 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2003 | 13655 | 0.010 |
Why?
|
| Lumbar Vertebrae | 1 | 2009 | 1844 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 4742 | 0.010 |
Why?
|
| Animals | 4 | 2010 | 168561 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2009 | 4328 | 0.010 |
Why?
|
| Cross-Sectional Studies | 2 | 2009 | 24913 | 0.010 |
Why?
|
| Adult | 2 | 2009 | 213712 | 0.010 |
Why?
|
| Drug Design | 1 | 2003 | 1078 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2009 | 3766 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2003 | 3689 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2009 | 9846 | 0.010 |
Why?
|
| Imidazoles | 1 | 2003 | 1205 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 2024 | 0.010 |
Why?
|
| Kinetics | 1 | 2003 | 6474 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2003 | 3557 | 0.010 |
Why?
|
| Genome, Human | 1 | 2008 | 4420 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2010 | 10472 | 0.010 |
Why?
|
| Binding Sites | 1 | 2003 | 6115 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2010 | 19223 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2003 | 1327 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2009 | 15056 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 5454 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 18355 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2003 | 8436 | 0.010 |
Why?
|
| Cell Line | 1 | 2003 | 15994 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2009 | 23320 | 0.000 |
Why?
|
| Kidney | 1 | 2003 | 7167 | 0.000 |
Why?
|
| Time Factors | 1 | 2009 | 40054 | 0.000 |
Why?
|
| Cell Line, Tumor | 1 | 2003 | 16665 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2009 | 40955 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2009 | 40450 | 0.000 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 5249 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2009 | 53187 | 0.000 |
Why?
|
| Child | 1 | 2009 | 77478 | 0.000 |
Why?
|
| Adolescent | 1 | 2009 | 85649 | 0.000 |
Why?
|
| Signal Transduction | 1 | 2003 | 23387 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 13019 | 0.000 |
Why?
|
| Mice | 1 | 2003 | 81045 | 0.000 |
Why?
|
Concepts
(121)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(17)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_